Overview
Founded in July 2021
in Shanghai, China, Teljane Medical specializes in the research, development
and industrialization of glucose monitoring technologies. The company combines
biosensor engineering with digital health to support more informed diabetes management.
Its Instara-1 continuous glucose monitoring (CGM) system uses a wearable sensor
to measure glucose in interstitial fluid and sends readings to a compatible
device every five minutes. With a 15-minute warm-up, Instara-1 is designed to
make continuous glucose insights part of everyday life.
Expertise in
Continuous Glucose Monitoring
Teljane Medical’s
expertise encompasses the following core capabilities:
Advanced Biosensor
Engineering : Multidisciplinary research spanning
biochemistry, microelectronics, materials science and algorithm engineering
supports the development of sensitive, long-life biosensors.
Wearable CGM
Technology : Instara-1 combines factory calibration with a
compact, 4.5 mm profile for discreet monitoring without routine user
calibration.
Glucose Monitoring
Accuracy :
Instara-1 has a reported mean absolute relative
difference (MARD) of 8.2%, providing a clinical measure of its glucose
monitoring accuracy.
Connected Diabetes
Insights : Glucose alerts, event logging, remote sharing
and reports on glucose trends and time in range bring daily monitoring data
together.
Quality Certifications
Teljane Medical achieved ISO 13485 and MDSAP certifications in 2024,
marking a key milestone in its medical device quality management.
Global Presence
Teljane’s research network includes laboratories in Shanghai and Silicon
Valley, established in 2021. Its international development includes market
expansion and licensing collaborations, while its partnership with JAT Medical
supports the introduction of CGM technologies to healthcare providers in Saudi
Arabia.
Partnership with JAT Medical
The collaboration connects Teljane’s capabilities in biosensors and
digital health with JAT Medical’s focus on serving healthcare professionals
across the Kingdom. Together, we aim to support a more connected approach to
diabetes care through clearer glucose visibility and more informed clinical
discussions.
JAT Medical partners with Teljane Medical to introduce glucose monitoring
solutions to the Saudi healthcare market and expand our Diabetes Care
portfolio.